(Press-News.org) A UCLA-led study has found that a combination of several key guideline-recommended therapies for heart failure treatment resulted in an improvment of up to 90 percent in the odds of survival over two years.
The research is published Feb. 21 in the online Journal of the American Heart Association.
Heart failure, a chronic, progressive disease, affects millions of individuals and results in morbidity, the use of significant health care resources, and substantial costs.
While certain therapies are recommended for heart failure patients in the national guidelines of the American College of Cardiology and the American Heart Association, this study is the first to examine the specific incremental contribution of each of these therapies in improving survival when combined together progressively in a real-world clinical practice, the researchers said.
"We found incremental and cumulative improvement in the odds of two-year survival rates as each of these guideline-recommended therapies was implemented with patients," said the study's first author, Dr. Gregg Fonarow, UCLA's Eliot Corday Professor of Cardiovascular Medicine and Science and director of the Ahmanson–UCLA Cardiomyopathy Center at the David Geffen School of Medicine at UCLA.
Fonarow noted that the findings also provide further rationale for employing performance-improvement systems and disease-management programs to ensure the implementation of recommended therapies in eligible heart failure patients.
For the study, researchers utilized the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF), a database of patients at 167 cardiology-practice clinics across the country.
The team reviewed medical chart data from 1,376 patients who died at 24 months, compared with 2,752 controls who survived to 24 months. Researchers specifically targeted patients who had weakening function in the heart's left venticle, a symptom of chronic heart failure, which occurs when the when the entricle can no longer pump enough blood to the body's other organs.
The seven key guideline-recommended therapies evaluated were:
Three types of heart failure medications: beta blockers, aldosterone antagonists, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
Cardiac resynchronization therapy, which helps coordinate heart contractions.
Anti-coagulant therapy for atrial fibrillation, to prevent clot formation in patients with an irregular heart beat.
Implantable cardioverter-defibrillator devices, to deliver electrical shocks if potentially fatal heart-rhythm abnormalities occur.
Heart-failure patient education.
Researchers found that as each therapy was added, the overall survival rate increased incrementally — starting with a 39 percent improved odds of two-year survival when just beta blockers were prescribed, and up to 81 percent to 90 percent when several other therapies were added — compared to no treatment at all.
However, the team found that the survival benefit appeared to plateau once a patient sequentially received four to five therapies, demonstrating an 83 percent reduction in the odds of 24-month mortality.
"Together the cumulative 24-month survival benefits of these therapies are impressive," said Fonarow, co-chief of clinical cardiology in the UCLA Division of Cardiology. "High-quality, patient-centered outcomes research is a national priority and can better inform clinical decision-making. This study provides patients, clinicians, purchasers and policymakers with compelling evidence of the incremental improvements in clinical outcomes for patients with heart failure that can be achieved with guideline-recommended therapies."
Each individual therapy, with a single exception, was also associated with a survival benefit. Beta blockers and cardiac resynchronization therapy imparted the greatest individual benefits by providing lowered odds of mortality of 42 percent and 44 percent, respectively.
Fonarow also noted that being able to independently value these heart failure therapies may provide a basis for choosing between treatments when a choice needs to be made on a clinical level, based on cost, tolerance or adherence issues.
The one therapy that was not associated with improved mortality benefit was the use of aldosterone antagonists. Fonarow said that while multiple randomized clinical trials have demonstrated the benefits of aldosterone antagonist therapy in heart failure patients, more study in an outpatient setting needs to be done to evaluate the real-world clinical effectiveness of these agents.
Medtronic Inc., a manufacturer of cardiac resynchronization therapy and implantable defibrillator devices, provided financial and material support for the IMPROVE HF registry. The company had no role or input in the selection of end-points or quality measures used in the study.
INFORMATION:
Fonarow has received honoraria and consultant fees from Medtronic. Additional author financial disclosures are listed in the study manuscript.
Other authors include Dr. Nancy M. Albert of the Heart Vascular Institute at the Cleveland Clinic Foundation; Dr. Anne B. Curtis of the department of medicine at the University at Buffalo; Dr. Mihai Gheorghiade of the Center for Cardiovascular Innovation at Northwestern University's Feinberg School of Medicine; J. Yang Liu of the department of statistics, CRDM, Medtronic Inc.; Mandeep R. Mehra of the division of cardiology at the University of Maryland School of Medicine; Dr. Christopher M. O'Connor of the division of cardiology at Duke University Medical Center; Dr. Dwight Reynolds of the division of cardiology at the University of Oklahoma Health Sciences Center; Dr. Mary Norine Walsh of the Care Group at St. Vincent Heart Center of Indiana; and Dr. Clyde W. Yancy of the division of cardiology at Northwestern University's Feinberg School of Medicine.
For more news, visit the Newsroom.ucla.edu and follow us on Twitter @UCLAnewsroom.
END
Patterns of brain development in the first two years of life are distinct in children who are later diagnosed with autism spectrum disorders (ASDs), according to researchers in a network funded by the National Institutes of Health. The study results show differences in brain structure at 6 months of age, the earliest such structural changes have been recorded in ASDs.
"The difference in the trajectory of brain development between the two groups was dramatic between 6 and 24 months," said senior author Joseph Piven, M.D., of the University of North Carolina, Chapel ...
The Massachusetts-based law firm of Cushing and Dolan, P.C. is pleased to announce a new timeslot for its long-running radio program, "Money Matters."
New Time
The radio program will be held every Wednesday between 12:00 p.m and 1:00 p.m. Eastern on the following channels:
- 830AM--WCRN
- 1390AM--WPLM
- 970AM--WESO
- 1120--WBNW
Call-In Information
Todd E. Lutsky, Esq., LLM of the firm will provide advice on tax and estate planning issues. Listeners with questions about tax and estate planning matters should call in at 888-759-5109. Todd will ...
Someday, your doctor may turn to you and say, "Take two surgeons and call me in the morning." If that day arrives, you may just have Ada Poon to thank.
Yesterday, at the International Solid-State Circuits Conference (ISSCC) before an audience of her peers, electrical engineer Poon demonstrated a tiny, wirelessly powered, self-propelled medical device capable of controlled motion through a fluid—blood more specifically. The era of swallow-the-surgeon medical care may no longer be the stuff of science fiction.
Poon is an assistant professor at the Stanford School of Engineering. ...
Unexpected illnesses, accidents and other health problems are a primary reason why many Americans are faced with the reality of a medical bankruptcy. Overwhelming medical debt is a primary cause of Chapter 7 and Chapter 13 bankruptcy filings in Arizona and throughout the U.S.
Recent survey results released by the Center for Studying Health System Change and the Robert Wood Johnson Foundation show that financial problems related to health care costs have increased over the past decade. The proportion of Americans who have experienced difficulty paying medical bills increased ...
RENO, Nev. – Just what does it mean to get a green card? To some applicants, about $1,000 each month.
A recent study by a University of Nevada, Reno economist and a graduate student found that employer-sponsored workers in the United States on temporary visas who acquire their green cards and become permanent residents increase their annual incomes by about $11,860. They studied data from The New Immigrant Survey, a collaborative study of new legal immigrants funded in 2003 by the U.S. Immigration and Naturalization Service and other public and private partners.
The ...
Deep-diving ocean "gliders" have revealed the journey of Bass Strait water from the Tasman Sea to the Indian Ocean.
Deployed in 2010 and 2011, the gliders have also profiled a 200-metre tall wall of water at the core of long-lived ocean eddies formed from the East Australian Current.The study, by University of Technology Sydney and CSIRO oceanographers, revealed the value of new sensors being deployed by Australia's Integrated Marine Observing System.
"We're getting a terrific amount of data that is opening up a very big window on Australia's oceans," UTS scientist ...
NEW ORLEANS – New research suggests women who have migraine or have had them in the past are at an increased risk for developing depression compared to women who have never had migraine. The study was released today and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012.
For the study, researchers classified 36,154 women without depression who were enrolled in the Women's Health Study and had provided information about migraine. Women were classified as either having active migraine with aura, active ...
Scientists have recently described the deepest terrestrial animal ever found, together with 4 new species for science. These animals are springtails (Arthropoda, Insecta, Collembola), a minute primitive wingless insect with six-legs and without eyes that live in total darkness.
Described by Rafael Jordana and Enrique Baquero from University of Navarra (Spain), they are known for science as: Anurida stereoodorata, Deuteraphorura kruberaensis, Schaefferia profundissima and Plutomurus ortobalaganensis. The last one is the deepest arthropod ever found, at the remarkable ...
WASHINGTON, DC, February 15, 2012 — Highly educated whites and minorities are no more likely to support workplace affirmative action programs than are their less educated peers, according to a new study in the March issue of Social Psychology Quarterly, which casts some doubt on the view that an advanced education is profoundly transformative when it comes to racial attitudes.
"I think this study is important because there's a common view that education is uniformly liberalizing, and this study shows—in a number of cases—that it's not," said study author Geoffrey T. Wodtke, ...
OAK BROOK, Ill. – Based on a study of nearly 2,000 breast cancer patients, researchers at the Swedish Cancer Institute in Seattle say that, in women between the ages of 40 and 49, breast cancers detected by mammography have a better prognosis. The study appears in the March issue of Radiology.
"In our study, women aged 40 to 49 whose breast cancer was detected by mammography were easier to treat and had less recurring disease and mortality, because their cancer was found at an earlier stage," said Judith A. Malmgren, Ph.D., president of HealthStat Consulting, Inc.
Dr. ...
